Decreased NO is a manifestation of endothelial dysfunction and is associated with decreased NO synthase activity (competitive inhibition by L-arginine or competitive inhibition by asymmetric dimethylarginine) or decreased NO bioavailability (overexpression of endothelin-1) (58–60). Here, EDN1 is linked to endothelial dysfunction.